Clinical Trials Browser

Interventional × Melanoma × famitinib × Clear all

NCT07517653 2026-04-08

Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable Mucosal Melanoma

Phase 2 Not yet recruiting

Melanoma

NCT05051865 2022-11-17

To Explore the Efficacy and Safety of Camrelizumab Combined With SHR1020 in the Treatment of Advanced Melanoma

Phase 2 Unknown

Melanoma